Latest news
Loading news…
OriCiro Genomics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Tokyo, Japan Founded 2018 1-10 employees For Profit
OriCiro Genomics develops and commercializes cell-free synthesis and amplification technologies of large DNA molecules.
OriCiro Genomics was acquired by Moderna in 2023 for $85M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 18
- Patents granted
- 2
- Trademarks
- 0
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $9M
Company Info
- Founded
- 2018
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 8
- HQ
- Tokyo, Japan
- Region
- Asia-Pacific (APAC)
- Exit date
- Jan 4, 2023
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- -0.3
- Last leadership hire
- Jul 20, 2021
Key People at OriCiro Genomics
President and CEO
CTO
Co-Founder
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to OriCiro Genomics
Loading news…
FAQs about OriCiro Genomics
People who checked this page also checked these
Browse the full Acquirezy directory.